全球抗发炎治疗药物市场规模、份额、趋势和成长分析报告（2026-2034年）

预计抗发炎药物市场将从 2025 年的 1,166.5 亿美元成长到 2034 年的 1,914.6 亿美元，2026 年至 2034 年的复合年增长率为 5.66%。

由于关节炎、气喘、发炎性肠道疾病和自体免疫疾病等发炎性疾病的盛行率不断上升，全球抗发炎药物市场正经历稳定成长。慢性发炎已成为全球主要的健康问题，推动了对有效治疗方案的需求。製药公司正致力于研发先进的抗发炎药物，以帮助缓解症状并提高患者的生活品质。

该市场的成长受多种因素驱动，包括药物研发技术的进步、健康意识的提高以及对药物研发投入的增加。生物製药疗法和标靶治疗因其能够提供更精准的治疗效果而日益普及。此外，全球人口老化和文明病的增加也进一步推动了整个医疗保健系统对抗发炎药物的需求。

未来几年，全球抗发炎药物市场预计将受益于持续的创新和不断扩大的临床研究。製药公司正在探索新的药物类别和联合治疗，以增强治疗效果。个人化医疗和生物製药的日益普及也有望为市场成长开闢新的途径。随着医疗保健支出的增加和医疗技术的不断进步，抗发炎药物市场预计将显着扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球抗发炎治疗药物市场：依药物类别划分

• 市场分析、洞察与预测
• 抗发炎生物製药
• 非类固醇消炎剂（NSAIDs）
• 其他的

第五章 全球抗发炎治疗药物市场：依应用划分

• 市场分析、洞察与预测
• 自体免疫疾病
• 呼吸系统疾病
• 其他的

第六章 全球抗发炎治疗药物市场：依给药途径划分

• 市场分析、洞察与预测
• 口服
• 注射
• 局部行政部门
• 吸入

第七章 全球抗发炎治疗药物市场：依通路划分

• 市场分析、洞察与预测
• 医院药房
• 零售药房
• 网路药房

第八章 全球抗发炎治疗药物市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • AbbVie Inc
  • Merck & Co. Inc
  • Johnson & Johnson Services Inc
  • Pfizer Inc
  • Novartis AG
  • GlaxoSmithKline Plc
  • Amgen Inc
  • F. Hoffmann-La Roche Ltd
  • AstraZeneca
  • Sanofi

The Anti-inflammatory Therapeutics Market size is expected to reach USD 191.46 Billion in 2034 from USD 116.65 Billion (2025) growing at a CAGR of 5.66% during 2026-2034.

The Global Anti-inflammatory Therapeutics Market is experiencing steady growth due to the increasing prevalence of inflammatory diseases such as arthritis, asthma, inflammatory bowel disease, and autoimmune disorders. Chronic inflammation has become a major health concern globally, leading to a rising demand for effective therapeutic solutions. Pharmaceutical companies are focusing on developing advanced anti-inflammatory drugs that help reduce symptoms and improve patient quality of life.

Several factors are contributing to the growth of this market, including advancements in drug discovery, increasing healthcare awareness, and growing investments in pharmaceutical research and development. Biologic therapies and targeted treatments are gaining popularity due to their ability to provide more precise treatment outcomes. Additionally, the aging global population and rising incidence of lifestyle-related diseases are further driving the demand for anti-inflammatory medications across healthcare systems.

In the coming years, the Global Anti-inflammatory Therapeutics Market is expected to benefit from continued innovation and expanding clinical research. Pharmaceutical companies are exploring new drug classes and combination therapies to enhance treatment effectiveness. The increasing adoption of personalized medicine and biologic therapies is also expected to open new avenues for market growth. With rising healthcare spending and ongoing medical advancements, the anti-inflammatory therapeutics market is poised for significant expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Drug Class

• Anti-inflammatory Biologics
• NSAIDs
• Others

By Application

• Auto-Immune Diseases
• Respiratory Conditions
• Others

By Route of Administration

• Oral
• Injection
• Topical
• Inhalation

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• AbbVie Inc, Merck Co Inc, Johnson Johnson Services Inc, Pfizer Inc, Novartis AG, GlaxoSmithKline plc, Amgen Inc, F HoffmannLa Roche Ltd, AstraZeneca, Sanofi
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET: BY DRUG CLASS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Class
• 4.2. Anti-inflammatory Biologics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. NSAIDs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Auto-Immune Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Respiratory Conditions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Injection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Inhalation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Drug Class
  • 8.2.2 By Application
  • 8.2.3 By Route Of Administration
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Drug Class
  • 8.3.2 By Application
  • 8.3.3 By Route Of Administration
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Drug Class
  • 8.4.2 By Application
  • 8.4.3 By Route Of Administration
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Drug Class
  • 8.5.2 By Application
  • 8.5.3 By Route Of Administration
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Drug Class
  • 8.6.2 By Application
  • 8.6.3 By Route Of Administration
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ANTI-INFLAMMATORY THERAPEUTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AbbVie Inc
  • 10.2.2 Merck & Co. Inc
  • 10.2.3 Johnson & Johnson Services Inc
  • 10.2.4 Pfizer Inc
  • 10.2.5 Novartis AG
  • 10.2.6 GlaxoSmithKline Plc
  • 10.2.7 Amgen Inc
  • 10.2.8 F. Hoffmann-La Roche Ltd
  • 10.2.9 AstraZeneca
  • 10.2.10 Sanofi